The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

OBJECTIVE: During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Int J Cardiol Heart Vasc
Główni autorzy: Braude, Philip, Carter, Ben, Short, Roxanna, Vilches-Moraga, Arturo, Verduri, Alessia, Pearce, Lyndsay, Price, Angeline, Quinn, Terence J., Stechman, Michael, Collins, Jemima, Bruce, Eilidh, Einarsson, Alice, Rickard, Frances, Mitchell, Emma, Holloway, Mark, Hesford, James, Barlow-Pay, Fenella, Clini, Enrico, Myint, Phyo Kyaw, Moug, Susan, McCarthy, Kathryn, Hewitt, Jonathan
Format: Artigo
Język:Inglês
Wydane: Elsevier 2020
Hasła przedmiotowe:
Original Paper
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7561344/
https://ncbi.nlm.nih.gov/pubmed/33083516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100660
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy